A 2020 Dr. Fauci YouTube Conversation About Pandemics and His History: National Institutes of Health Begins Study to Quantify Undetected Cases of Coronavirus Infection
The study will be conducted by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB), with additional support from the National Center for Advancing Translational Sciences (NCATS) and the National Cancer Institute (NCI), all parts of NIH.
Dr. Anthony Fauci, right, NIH photo; Courtesy National Institute of Allergy and Infectious Diseases, 1981*
“This study will give us a clearer picture of the true magnitude of the COVID-19 pandemic in the United States by telling us how many people in different communities have been infected without knowing it, because they had a very mild, undocumented illness or did not access testing while they were sick,” said Anthony S. Fauci, M.D., NIAID director. “These crucial data will help us measure the impact of our public health efforts now and guide our COVID-19 response moving forward.”
Investigators will test participants’ blood samples for the presence of SARS-CoV-2 antibodies, proteins the immune system produces to fight a specific infectious agent. A positive test result indicates previous infection. To date, reporting of U.S. cases of COVID-19 has mostly relied on molecular tests that determine the presence of the virus in a person’s airways using a noninvasive cotton swab. While these cotton swab-based tests rapidly and effectively identify active infection, they do not determine whether a person was previously infected with SARS-CoV-2 and recovered.
After enrollment, study participants will attend a virtual clinic visit, complete a health assessment questionnaire and provide basic demographic information—including race, ethnicity, sex, age and occupation—before submitting samples in one of two ways. Participants working at the NIH Bethesda campus will have blood drawn at the NIH Clinical Center. Other volunteers will participate in at-home blood sampling. Neoteryx, a medical device firm based in Torrance, California, will supply at-home blood collection kits. Researchers will ship each study participant a Mitra®Home Blood Collection Kit and provide detailed instructions on collecting a microsample of blood and mailing it back for future analysis in the laboratory.
“Researchers have considerable experience using these at-home blood collection kits to track the spread of other infectious diseases like influenza, and this method is safe, effective and easy-to-use,” said Kaitlyn Sadtler, Ph.D., study lead for laboratory testing and chief of NIBIB’s Section for Immunoengineering. “With a small finger-pick, volunteers can help scientists fight COVID-19 from their homes.”
People interested in joining this study should contact clinicalstudiesunit@nih.gov . For more information on this study, please visit ClinicalTrials.gov using identifier NCT04334954. For more information on the U.S. government response to the COVID-19 pandemic, visit www.coronavirus.gov.
NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®
*Editor's Note: A YouTube Interview With Dr. Fauci at his New York City High School, Regis: https://www.youtube.com/watch?v=3hpWUciWKXg&feature=youtu.be&fbclid=IwAR1aiu6SiVmOBK7ejGuaalYRH04yUaioZx6TdB4923DDQRjhSsILXFoz_Y0
More Articles
- A Yale Medicine Doctor Explains How Naloxone, a Medication That Reverses an Opioid Overdose, Works
- Congressional Budget Office: Federal Budget Deficit Totals $1.4 Trillion in 2023; Annual Deficits Average $2.0 Trillion Over the 2024–2033 Period
- Remarks by Secretary of the Treasury Janet L. Yellen at the Bureau of Engraving and Printing Facility in Fort Worth, Texas
- At "Toward an Inclusive Recovery," a research seminar sponsored by the Board of Governors of the Federal Reserve System, Washington, D.C.
- GAO High Risk List, Public Health Preparedness: *HHS Should Address Strategic National Stockpile Requirements and Inventory Risks
- Center for Strategic and International Studies: “The Future Outlook with Dr. Anthony Fauci”
- Statement by Anthony S. Fauci, M.D.: Inspiring and Mentoring the Next Generation of Scientific Leaders As They Help Prepare the World to Face Future Infectious Disease Threats
- Kaiser Health News Research Roundup: Pan-Coronavirus Vaccine; Long Covid; Supplemental Vitamin D; Cell Movement
- *GAO Report on Pandemic Learning: Less Academic Progress Overall, Student and Teacher Strain, and Implications for the Future GAO-22-105816 Published: Jun 08, 2022. Publicly Released: Jun 08, 2022
- GAO, Unemployment Insurance: Transformation Needed to Address Program Design, Infrastructure, and Integrity Risks
